Elevated hCG can be a benign finding in perimenopausal and postmenopausal women

Area of Science:

• Endocrinology
• Reproductive Medicine
• Oncology

Background:

• Elevated human chorionic gonadotropin (hCG) in perimenopausal and postmenopausal women typically raises concerns for malignancy or pregnancy.
• However, pituitary production of hCG can present as a benign physiologic finding in this demographic.
• Underrecognition of pituitary hCG can lead to misdiagnosis and inappropriate medical interventions.

Purpose of the Study:

• To highlight the significance of pituitary human chorionic gonadotropin (hCG) production in perimenopausal and postmenopausal women.
• To emphasize the diagnostic challenges and potential consequences of overlooking a pituitary source of hCG.
• To advocate for the development of guidelines for evaluating elevated hCG in this population.

Main Methods:

• Literature review on human chorionic gonadotropin (hCG) production in women.
• Analysis of clinical cases presenting with elevated hCG.
• Review of diagnostic criteria and management strategies for hCG elevation.

Main Results:

• Pituitary hCG production is an underrecognized cause of elevated hCG in menopausal women.
• Failure to consider pituitary hCG can lead to unnecessary investigations, including chemotherapy.
• Misdiagnosis can delay appropriate care for unrelated conditions.

Conclusions:

• Pituitary hCG production is a critical differential diagnosis in menopausal women with elevated hCG.
• Establishing clear diagnostic guidelines is essential to prevent overtreatment and ensure timely care.
• Increased awareness among clinicians can improve patient outcomes by avoiding unnecessary interventions.